{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:41:34Z","timestamp":1789627294259,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"3-D Matrix Europe SAS, Caluire-et-Cuire, France"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00464-025-12374-0","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T21:55:27Z","timestamp":1764626127000},"page":"1549-1558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential role of a synthetic peptide hydrogel in accelerating mucosal defect healing: evidence from a porcine model"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3583-2651","authenticated-orcid":false,"given":"Ilja","family":"Tachec\u00ed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0151-9982","authenticated-orcid":false,"given":"\u0160t\u011bp\u00e1n","family":"\u0160embera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Zimandlov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Mor\u00e1vkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina Geisler","family":"Vejvalkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u011bra","family":"Radochov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale\u0161","family":"Ry\u0161ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Cyrany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"12374_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2024.07.023","author":"S Shinozaki","year":"2025","unstructured":"Shinozaki S, Hayashi Y, Sakamoto H et al (2025) PURPLE multicenter trial: randomized controlled evaluation of PuraStat for prevention of delayed bleeding after colorectal EMR. Gastrointest Endosc. https:\/\/doi.org\/10.1016\/j.gie.2024.07.023","journal-title":"Gastrointest Endosc"},{"key":"12374_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1055\/a-1224-7231","volume":"52","author":"S Subramaniam","year":"2020","unstructured":"Subramaniam S, Kandiah K, Thayalasekaran S, Longcroft-Wheaton G, Bhandari P (2020) Clinical application of a novel self-assembling peptide for hemostasis and defect healing after ESD. Endosc 52:314\u2013322. https:\/\/doi.org\/10.1055\/a-1224-7231","journal-title":"Endosc"},{"key":"12374_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/deo2.225","author":"K Gomi","year":"2023","unstructured":"Gomi K, Iizuka T, Kobayashi T, Gotoda T (2023) Use of a synthetic peptide hydrogel after gastric endoscopic submucosal dissection: a Japanese multicenter study. DEN Open. https:\/\/doi.org\/10.1002\/deo2.225","journal-title":"DEN Open"},{"key":"12374_CR4","unstructured":"Council of Europe (1986) Explanatory report on the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes. Council of Europe, Strasbourg"},{"key":"12374_CR5","unstructured":"U.S. Food and Drug Administration (2021) 510(k) premarket notification K210098, summary, in: \u201cHemostatic device for endoscopic gastrointestinal use\u201d; PuraStat\u00ae. 3-D Matrix Inc. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K210098"},{"key":"12374_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.679525","volume":"9","author":"S Sankar","year":"2021","unstructured":"Sankar S, O\u2019Neill K, Bagot D\u2019Arc M, Rebeca F, Buffier M, Aleksi E et al (2021) Clinical use of the self-assembling peptide RADA16: a review of current and future trends in biomedicine. Front Bioeng Biotechnol 9:679525. https:\/\/doi.org\/10.3389\/fbioe.2021.679525","journal-title":"Front Bioeng Biotechnol"},{"key":"12374_CR7","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.gie.2015.11.039","volume":"83","author":"T Uraoka","year":"2016","unstructured":"Uraoka T, Ochiai Y, Fujimoto A, Goto O, Kawahara Y, Kobayashi N et al (2016) A novel fully synthetic and self-assembled peptide solution for endoscopic submucosal dissection-induced ulcer in the stomach. Gastrointest Endosc 83:1259\u20131264. https:\/\/doi.org\/10.1016\/j.gie.2015.11.039","journal-title":"Gastrointest Endosc"},{"key":"12374_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/gels9080653","volume":"9","author":"S Li","year":"2023","unstructured":"Li S, Yu Q, Li H, Chen M, Jin Y, Liu D (2023) Self-assembled peptide hydrogels in regenerative medicine. Gels 9:653. https:\/\/doi.org\/10.3390\/gels9080653","journal-title":"Gels"},{"key":"12374_CR9","doi-asserted-by":"publisher","first-page":"E1220","DOI":"10.1055\/a-2406-7492","volume":"12","author":"R Maselli","year":"2024","unstructured":"Maselli R, Da Rio L, Manno M, Soriani P, Andrisani G, Di Matteo FM et al (2024) Efficacy of novel endoscopic hemostatic agent for bleeding control and prevention: results from a prospective, multicenter national registry. Endosc Int Open 12:E1220\u2013E1229. https:\/\/doi.org\/10.1055\/a-2406-7492","journal-title":"Endosc Int Open"},{"key":"12374_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.gie.2023.05.046","volume":"98","author":"K Kasuga","year":"2023","unstructured":"Kasuga K, Yamashina T, Konishi H, Nagai K, Takahashi S, Tominaga K et al (2023) Endoscopic tissue shielding with polyglycolic acid sheets, self-assembling peptide, and endoclips for preventing delayed adverse events after endoscopic submucosal dissection. Gastrointest Endosc 98:435\u2013445. https:\/\/doi.org\/10.1016\/j.gie.2023.05.046","journal-title":"Gastrointest Endosc"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12374-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-025-12374-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12374-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:06:02Z","timestamp":1770404762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-025-12374-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["12374"],"URL":"https:\/\/doi.org\/10.1007\/s00464-025-12374-0","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the Cooperatio Program,\u00a0research area INDI.This study was financially and materially supported by 3-D Matrix Europe SAS, Caluire-et-Cuire, France. The sponsor had no role in the design, conduct, data collection, analysis, or interpretation of the study. The authors declare no personal financial or institutional conflicts of interest.Dr. Ilja Tachec\u00ed reports institutional funding from 3-D Matrix Europe SAS and the Cooperatio Program, research area INDI, for this study. He received travel support (SuppMed, 3-D Matrix Europe SAS) and serves as President of the Czech Society of Gastroenterology (unpaid role), received speaker honoraria from PRO.MED.CS Praha a.s., Novantin s.r.o. and tutor honoraria from Olympus.Dr. \u0160t\u011bp\u00e1n \u0160embera reports lecture honoraria from PRO.MED.CS Praha a.s., traineeship support from ESGE training grant, Endowment Fund of the Czech Hepatology Society and Endowment Fund HKMED, travel support from Celltrion Healthcare CZ and PRO.MED.CS Praha a.s.Dr. Kate\u0159ina Geisler Vejvalkov\u00e1 has no conflicts of interest or financial ties to disclose.Dr. Paula Mor\u00e1vkov\u00e1 received travel support (AbbVie, Takeda).Dr. V\u011bra Radochova has no conflicts of interest or financial ties to disclose.Dr. Dana Zimandlov\u00e1 has no conflicts of interest or financial ties to disclose.Dr. Ale\u0161 Ry\u0161ka has served on advisory boards for Amgen, AstraZeneca, Bayer, BMS, Eli Lilly, Gilead, Merck, MSD, Pfizer, Pierre Fabre, Roche, and Sanofi; received speaker honoraria from Amgen, AstraZeneca, Bayer, BMS, Eli Lilly, Gilead, Merck, MSD, Pfizer, Pierre Fabre, and Roche; and travel support from Gilead, Pierre Fabre, and Sanofi. He is Immediate Past President of the European Society of Pathology (unpaid role).Dr. Jiri Cyrany received travel support from SuppMed and serves as a board member of the Czech Society of Gastroenterology (unpaid role).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}